Company intelligence / Profile preview

Luminova

Ownership: Private
Development stage: Commercial

Overview

Luminova Biotech is a preclinical-stage biotechnology company developing gene and optogenetics-based therapies aimed at enhancing mitochondrial function. Their proprietary mtON technology is being leveraged to address age-related vision loss, with broader long-term goals in general aging and longevity.

Therapeutic areas: OtherOphthalmology
Modalities: Gene therapyOptogenetics-based therapy
Industry: Biotech

Drug pipeline

1 asset

Hair Revive Spray

Commercial

Indications: Hair loss

Beyond the preview

Go deeper on Luminova.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Luminova.

Explore the full profile